Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.

@article{Goldstein2015GastrointestinalBI,
  title={Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.},
  author={Daniel J. Goldstein and Keith David Aaronson and Antone J. Tatooles and Scott C. Silvestry and Valluvan Jeevanandam and Robert A Gordon and David R. Hathaway and Kevin B Najarian and Mark S. Slaughter},
  journal={JACC. Heart failure},
  year={2015},
  volume={3 4},
  pages={
          303-13
        }
}
OBJECTIVES This study evaluated gastrointestinal bleeding (GIB) in patients receiving the HeartWare HVAD System (HeartWare Inc., Framingham, Massachusetts) in the pivotal BTT (Bridge to Transplant) trial and under the continued access protocol (CAP). BACKGROUND GIB has become a significant problem for recipients of continuous flow device left ventricular assist devices (CF-LVAD). The need for anticoagulation and antiplatelet therapies complicates the management of GIB. METHODS Bleeding… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Similar Papers

Loading similar papers…